Cell Stiffness Is a Biomarker of the Metastatic Potential of Ovarian Cancer Cells
Citations Over TimeTop 1% of 2012 papers
Abstract
The metastatic potential of cells is an important parameter in the design of optimal strategies for the personalized treatment of cancer. Using atomic force microscopy (AFM), we show, consistent with previous studies conducted in other types of epithelial cancer, that ovarian cancer cells are generally softer and display lower intrinsic variability in cell stiffness than non-malignant ovarian epithelial cells. A detailed examination of highly invasive ovarian cancer cells (HEY A8) relative to their less invasive parental cells (HEY), demonstrates that deformability is also an accurate biomarker of metastatic potential. Comparative gene expression analyses indicate that the reduced stiffness of highly metastatic HEY A8 cells is associated with actin cytoskeleton remodeling and microscopic examination of actin fiber structure in these cell lines is consistent with this prediction. Our results indicate that cell stiffness may be a useful biomarker to evaluate the relative metastatic potential of ovarian and perhaps other types of cancer cells.
Related Papers
- → Resonance Raman spectroscopic evaluation of skin carotenoids as a biomarker of carotenoid status for human studies(2013)110 cited
- → Supporting evidence for using biomarkers in the diagnosis of MCI due to AD(2012)55 cited
- → Thioredoxin 1 as a serum marker for ovarian cancer and its use in combination with CA125 for improving the sensitivity of ovarian cancer diagnoses(2014)16 cited
- → P2‐215: Supporting evidence of the Alzheimer's disease biomarker dynamic model in patients with mild cognitive impairment(2012)1 cited
- → P4‐123: Resolving Conflicting CSF Biomarker Information in Alzheimer′s Disease(2016)